| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0706 | ari-3531 | Novel selective inhibitor of PREP, displaying great selectivity over FAP, while also not inhibiting the DPPs. |
|
| DCC0707 | arkin-1 | Novel inhibitor of Ark1, the fission yeast member of the conserved Aurora kinase family |
|
| DCC0708 | Arl-67085 | P2T (P2YADP) purinoceptor antagonist |
|
| DCC0709 | Arl-67156 | Selective ecto-ATPase inhibitor, preventing metabolism of P2 purinoceptor agonists |
|
| DCC0710 | Armeniaspirol A | Natural inhibitor of recombinant purified ClpXP and ClpYQ AAA+ proteases, exhibitung potent antibacterial activity against H. pylori, including multidrug-resistant strains |
|
| DCC0711 | Armillarisin A | Regulator and promotor of immune functions, enhancing the role of macrophages, inhibiting bacteria growth, improving the protein metabolism, and regulating liver function |
|
| DCC0712 | Arn2508 | Novel dual inhibitor of the fatty acid amide hydrolase (FAAH) and the cyclooxygenase (COX) enzymes |
|
| DCC0713 | Arn-810 Analog | Novel selective estrogen receptor degrader (SERD), inducing regression in a tamoxifen-resistant breast cancer xenograft |
|
| DCC0714 | Arq736 | Novel potent and selective BRAF inhibitor |
|
| DCC0715 | ar-r17779 | Selective alpha-7 agonist |
|
| DCC0716 | Arsai 1r | The first human arylsulfatase A reversible inhibitor, impairing mouse oocyte fertilization |
|
| DCC0717 | arvelexin | Inhibitor of the inflammatory responses via NF |
|
| DCC0718 | Arzoxifene Hydrochloride | Non-steroidal selective estrogen receptor modulator (SERM) |
|
| DCC0719 | As-0141 | Novel Potent and Selective Inhibitor of CDC7 Kinase for the Treatment of Solid Cancers |
|
| DCC0720 | As057278 | Inhibitor of D-amino acid oxidase (DAAO) |
|
| DCC0721 | As1069562 | Inhibitor of serotonin (5-HT) and norepinephrine (NE) reuptake, significantly restoring decreased insulin-like growth factor 1 and fibroblast growth factor 2 mRNA levels in dorsal root ganglion and spinal cord, respectively |
|
| DCC0722 | As1468240 | Potent factor Xa inhibitor with significant oral anticoagulant activity |
|
| DCC0723 | as1669058 | Novel GPR119 agonist, potentiating insulin secretion from rat islets and having potent anti-diabetic effects in ICR and diabetic db/db mice |
|
| DCC0724 | As1670542 | Second-generation potent orally-active thrombopoietin (TPO) receptor agonist |
|
| DCC0725 | As1708727 | Novel Foxo1 inhibitor, exerting anti-diabetic and anti-hypertriglyceridemic effects by improving blood glucose and triglyceride metabolism at the gene expression level |
|
| DCC0726 | As1938909 | Novel SHIP2 inhibitor, increasing Akt phosphorylation, glucose consumption, and glucose uptake in L6 myotubes, specifically upregulating the GLUT1 gene |
|
| DCC0727 | As2034178 | Novel GPR40 agonist |
|
| DCC0728 | As3334034 | Novel Receptor-interacting Protein Kinase 2 (RIP2) Inhibitor |
|
| DCC0729 | As-703569 | Selective inhibitor of aurora kinases (AKs) |
|
| DCC0730 | Asah1-in-e2 | Novel angiogenesis inhibitor, directly binding to acid ceramidase 1 (ASAH1) |
|
| DCC0731 | Asc-082 | Novel inhibitor of inositol-requiring enzyme 1 (IRE-1), also inhibiting G protein-coupled receptor kinase 6 (GRK6) |
|
| DCC0732 | Ascochlorin | Natural Suppressor of MMP-2-Mediated Migration and Invasion by Targeting FAK and JAK-STAT Signaling Cascades |
|
| DCC0733 | Ask1 Inhibitor 32 | Novel, Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Modulating Brain Inflammation In Vivo |
|
| DCC0734 | Asm-024 | Novel modulator of acetylcholine receptor function, promoting the in vitro relaxation of β2-adrenoreceptor desensitized tracheas |
|
| DCC0735 | Asm-in-21b | Novel, Potent, Selective, and Direct Acid Sphingomyelinase (ASM) Inhibitor with Antidepressant Activity |
|
